Announced Thu, 15 Oct, 2026 · 11:29 IST

RTA submits Q2 FY27 demat compliance certificate to BSE

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹4.52

prior close

₹4.43

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-0.3% vs market

Commodity Chemicals peers, median of 58sector-0.6%-1.4% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 1.4 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.0-1.6-0.3-0.6-1.4

Next day

-3.8-1.0-2.8-0.8-3.0

-5.5-2.6-2.9-2.6-3.0

-7.3-5.1-2.2-4.7-2.6

-9.1-6.1-3.0-5.5-3.5

-9.3-8.3-1.0-9.3+0.0

-11.1-6.4-4.7-7.0-4.1

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 58Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KOBO Biotech filed a certificate from its Registrar and Share Transfer Agent, XL Softech Systems, under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The RTA confirmed that all securities received for dematerialization were verified with depositories, listed on the stock exchange, and the depositories were recorded as registered owners within 30 days. The filing was signed by Namrata Randeri, Chairman of the Management Committee.

Likely market impact

Routine quarterly compliance filing. No material business impact. No shareholder action required.